tert-Butyl 3-hydroxy-4-oxopiperidine-1-carboxylate, 95.0%, 5g

5-Methoxy-1H-pyrazole, 95.0%, 250mg

Ethyl 4-(4,4-dimethylpiperidin-1-yl)benzoate, 95.0%, 5g

Bis[2-[2-(2-chloroethoxy)ethoxy]ethyl]ether>97.0%(GC)5g

3-BROMO-5-CHLORO-1,6-NAPHTHYRIDINE, 95.0%, 5g

3-(tert-Butyldimethylsilyloxy)glutaric anhydride, 95.0%, 25g

(1S,2S)-2-Amino-1-(4-aminophenyl)propane-1,3-diol, 98.0%, 100mg

L-kynurénine, min 98%, pour la biochimie, 250 mg, conditionnement en verre

1-(2,5-Dimethylfuran-3-yl)ethanone, 95.0%, 100g

Methyl 4-bromo-1,2,5-thiadiazole-3-carboxylate, 95.0%, 1g

3-(1,3-Dioxo-1,3-dihydroisoindol-2-yl)-propionaldehyde, 95.0%, 10g

(2E)-1-(3-bromophenyl)-3-(2,5-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

2-Dimethylamino-4-methyl-thiazole-5-carboxylic acid, 100mg